Skip to content
XPR – Lifestyle Demo
Author:
Paratus Sciences Corporation
Paratus Sciences Presents Preclinical and Translational Data on PS-1001, a First-in-Class Pan-Inflammasome Inhibitor, at FOCIS 2026
June 11, 2026
Paratus Appoints Alicia Secor as President and Chief Executive Officer; Expands Leadership Team to Support Next Phase of Growth
April 22, 2026